Patients volunteer for trials for mostly altruistic reasons - they want to improve outcomes for others. That said, the informed consent process also allows them to gauge whether the procedure being offered is likely to be better (or the same) as the status quo.
Prof Bart Meuris (https://infomeddnews.com/valve-durability-in-tavr-is-a-critical-factor-for-the-future/) is the administering surgeon and has been working with Admedus on this for more than 5 years. He will have full and frank discussions with these patients as to whether the Admedus valve is right for them. He wouldn't be offering it if he didn't believe in it.
- Forums
- ASX - By Stock
- AVR
- Ann: Coronavirus Mitigation Strategy
Ann: Coronavirus Mitigation Strategy, page-10
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.97 |
Change
-0.235(1.29%) |
Mkt cap ! $345.3M |
Open | High | Low | Value | Volume |
$18.09 | $18.09 | $17.88 | $1.182K | 66 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 60 | $17.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.05 | 554 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60 | 17.880 |
1 | 47 | 17.870 |
1 | 619 | 17.860 |
1 | 37 | 17.650 |
2 | 700 | 17.550 |
Price($) | Vol. | No. |
---|---|---|
18.050 | 554 | 1 |
18.100 | 1000 | 1 |
18.200 | 343 | 2 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
Last trade - 14.30pm 10/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online